Cargando…
Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial
AIMS: Restoration of myocardial blood flow and perfusion during percutaneous coronary intervention (PCI) measured using Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG) and perfusion grade (TMPG) is associated with improved outcomes in acute coronary syndrome (ACS). Associations between...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173680/ https://www.ncbi.nlm.nih.gov/pubmed/35213721 http://dx.doi.org/10.1093/ehjacc/zuac020 |
_version_ | 1784722073227100160 |
---|---|
author | Batra, Gorav Renlund, Henrik Kunadian, Vijay James, Stefan K Storey, Robert F Steg, P Gabriel Katus, Hugo A Harrington, Robert A Gibson, C Michael Budaj, Andrzej Siegbahn, Agneta Wallentin, Lars |
author_facet | Batra, Gorav Renlund, Henrik Kunadian, Vijay James, Stefan K Storey, Robert F Steg, P Gabriel Katus, Hugo A Harrington, Robert A Gibson, C Michael Budaj, Andrzej Siegbahn, Agneta Wallentin, Lars |
author_sort | Batra, Gorav |
collection | PubMed |
description | AIMS: Restoration of myocardial blood flow and perfusion during percutaneous coronary intervention (PCI) measured using Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG) and perfusion grade (TMPG) is associated with improved outcomes in acute coronary syndrome (ACS). Associations between TFG/TMPG and changes in biomarkers reflecting myocardial damage/dysfunction and inflammation is unknown. METHODS AND RESULTS: Among 2606 patients included, TFG was evaluated in 2198 and TMPG in 1874 with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment ACS (NSTE-ACS). Biomarkers reflecting myocardial necrosis [troponin T (TnT)], myocardial dysfunction [N-terminal prohormone brain natriuretic peptide (NT-proBNP)], inflammation [interleukin-6 (IL-6) and C-reactive protein (CRP)], and oxidative stress/ageing/inflammation [growth differentiation factor-15 (GDF-15)] were measured at baseline, discharge, and 1- and 6-month post-randomization. Associations between TFG/TMPG and changes in biomarker levels were evaluated using the Mann–Whitney–Wilcoxon signed test. In total, 1423 (54.6%) patients had STEMI and 1183 (45.4%) NSTE-ACS. Complete reperfusion after PCI with TFG = 3 was achieved in 1110 (85.3%) with STEMI and in 793 (88.5%) with NSTE-ACS. Normal myocardial perfusion with TMPG = 3 was achieved in 475 (41.6%) with STEMI and in 396 (54.0%) with NSTE-ACS. Levels of TnT, NT-proBNP, IL-6, CRP, and GDF-15 were substantially lower at discharge in patients with complete vs. incomplete TFG and STEMI (P < 0.01). This pattern was not observed for patients with NSTE-ACS. Patients with normal vs. abnormal TMPG and NSTE-ACS had lower levels of NT-proBNP at discharge (P = 0.01). CONCLUSIONS: Successful restoration of epicardial blood flow in STEMI was associated with less myocardial necrosis/dysfunction and inflammation. Attainment of normal myocardial perfusion was associated with less myocardial dysfunction in NSTE-ACS. |
format | Online Article Text |
id | pubmed-9173680 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91736802022-06-08 Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial Batra, Gorav Renlund, Henrik Kunadian, Vijay James, Stefan K Storey, Robert F Steg, P Gabriel Katus, Hugo A Harrington, Robert A Gibson, C Michael Budaj, Andrzej Siegbahn, Agneta Wallentin, Lars Eur Heart J Acute Cardiovasc Care Original Scientific Paper AIMS: Restoration of myocardial blood flow and perfusion during percutaneous coronary intervention (PCI) measured using Thrombolysis in Myocardial Infarction (TIMI) flow grade (TFG) and perfusion grade (TMPG) is associated with improved outcomes in acute coronary syndrome (ACS). Associations between TFG/TMPG and changes in biomarkers reflecting myocardial damage/dysfunction and inflammation is unknown. METHODS AND RESULTS: Among 2606 patients included, TFG was evaluated in 2198 and TMPG in 1874 with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment ACS (NSTE-ACS). Biomarkers reflecting myocardial necrosis [troponin T (TnT)], myocardial dysfunction [N-terminal prohormone brain natriuretic peptide (NT-proBNP)], inflammation [interleukin-6 (IL-6) and C-reactive protein (CRP)], and oxidative stress/ageing/inflammation [growth differentiation factor-15 (GDF-15)] were measured at baseline, discharge, and 1- and 6-month post-randomization. Associations between TFG/TMPG and changes in biomarker levels were evaluated using the Mann–Whitney–Wilcoxon signed test. In total, 1423 (54.6%) patients had STEMI and 1183 (45.4%) NSTE-ACS. Complete reperfusion after PCI with TFG = 3 was achieved in 1110 (85.3%) with STEMI and in 793 (88.5%) with NSTE-ACS. Normal myocardial perfusion with TMPG = 3 was achieved in 475 (41.6%) with STEMI and in 396 (54.0%) with NSTE-ACS. Levels of TnT, NT-proBNP, IL-6, CRP, and GDF-15 were substantially lower at discharge in patients with complete vs. incomplete TFG and STEMI (P < 0.01). This pattern was not observed for patients with NSTE-ACS. Patients with normal vs. abnormal TMPG and NSTE-ACS had lower levels of NT-proBNP at discharge (P = 0.01). CONCLUSIONS: Successful restoration of epicardial blood flow in STEMI was associated with less myocardial necrosis/dysfunction and inflammation. Attainment of normal myocardial perfusion was associated with less myocardial dysfunction in NSTE-ACS. Oxford University Press 2022-02-25 /pmc/articles/PMC9173680/ /pubmed/35213721 http://dx.doi.org/10.1093/ehjacc/zuac020 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Scientific Paper Batra, Gorav Renlund, Henrik Kunadian, Vijay James, Stefan K Storey, Robert F Steg, P Gabriel Katus, Hugo A Harrington, Robert A Gibson, C Michael Budaj, Andrzej Siegbahn, Agneta Wallentin, Lars Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial |
title | Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial |
title_full | Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial |
title_fullStr | Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial |
title_full_unstemmed | Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial |
title_short | Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial |
title_sort | effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with st-segment and non-st-segment elevation acute coronary syndrome: results from the platelet inhibition and patients outcomes (plato) trial |
topic | Original Scientific Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173680/ https://www.ncbi.nlm.nih.gov/pubmed/35213721 http://dx.doi.org/10.1093/ehjacc/zuac020 |
work_keys_str_mv | AT batragorav effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT renlundhenrik effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT kunadianvijay effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT jamesstefank effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT storeyrobertf effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT stegpgabriel effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT katushugoa effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT harringtonroberta effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT gibsoncmichael effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT budajandrzej effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT siegbahnagneta effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial AT wallentinlars effectsofearlymyocardialreperfusionandperfusiononmyocardialnecrosisdysfunctionandinflammationinpatientswithstsegmentandnonstsegmentelevationacutecoronarysyndromeresultsfromtheplateletinhibitionandpatientsoutcomesplatotrial |